Adherence to microsatellite instability testing in young-onset colorectal cancer patients

Diseases of the Colon and Rectum

Volumn 56, Issue 7, 2013, Pages 825-833

  Kessels, Koen ^a   Fidder, Herma H ^a   De Groot, Nicolette L ^a   Letteboer, Tom G ^a   Timmer, Robin ^b   Van Dalen, Thijs ^c   Consten, Esther C ^d   Offerhaus, G Johan A ^a   Siersema, Peter D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

Colon cancer; Hereditary nonpolyposis colorectal cancer; Screening

Indexed keywords

ADULT; ARTICLE; COLORECTAL CANCER; DATA BASE; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NETHERLANDS; PRACTICE GUIDELINE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADULT; AGE OF ONSET; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; INCIDENCE; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NETHERLANDS; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84879159411     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31828b6617     Document Type: Article

References (39)

1. Comprehensive Cancer Center the Netherlands (IKNL). Dutch Cancer Figures, The Netherlands, 2012. Available at: http://www.cijfersoverkanker.nl/selecties/ dataset-2/img 50db1e5ed46c0 Accessed December 26, 2012.
2. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919-932.
3. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769-780.
4. Lynch HT, Riley BD, Weissman SM, et al. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: problems in diagnosis, surveillance, and management. Cancer. 2004;100:53-64.
5. Lynch HT, Smyrk T, Lynch JF. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). Int J Cancer. 1996;69:38-43.
6. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296:1507-1517.
7. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481-1487.
8. de la Chapelle A. Microsatellite instability. N Engl J Med. 2003;349:209-210.
9. Vasen HF, Möslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007;44:353-362.
10. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
11. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-1456.
12. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758-1762.
13. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
14. Van Lier MG, De Wilt JH, Wagemakers JJ, et al. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome. Scand J Gastroenterol. 2009;44:600-604.
15. Anning L, Koo N, Neely J, et al. Management of young onset colorectal cancer: divergent practice in the East of England. Colorectal Dis. 2011;13:e297-e302.
16. Staal-Rosier PM, Rabeling-Keus IM, Kruyt M. Inadequate referral for genetic evaluations of patients with colorectal carcinoma [in Dutch]. Ned Tijdschr Geneeskd. 2009;153:124-128.
17. Overbeek LI, Hoogerbrugge N, van Krieken JH, et al.; MIPA Study Group. Most patients with colorectal tumors at young age do not visit a cancer genetics clinic. Dis Colon Rectum. 2008;51:1249-1254.
18. Singh H, Schiesser R, Anand G, Richardson PA, El-Serag HB. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol. 2010;8:523-529.
19. Koehler-Santos P, Izetti P, Abud J, et al. Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic. World J Gastroenterol. 2011;17:766-773.
20. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011;60:950-957.
21. Järvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
22. Järvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15- year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829-834.
23. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006;354:261-269.
24. Wong C, Gibbs P, Johns J, et al. Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing? Intern Med J. 2008;38:328-333.
25. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
26. Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol. 2011;46:1340-1348.
27. Kessels K, de Groot NL, Fidder HH, et al. Recording of family history is associated with colorectal cancer stage Eur J Gastroenterol Hepatol. 2013;25:482-487.
28. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609-618.
29. de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380-3387.
30. Oncoline Cancer Clinical Practice Guidelines. National Working Group on Gastrointestinal Cancers, Type: Nationwide Guideline, 2008. Available at: http://www.oncoline.nl/index. php?pagina=/richtlijn/item/pagina. php&richtlijn-id=598 Accessed December 11, 2012.
31. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998;42: 673-679.
32. Rijcken FE, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut. 2002;50:382-386.
33. Jenkins MA, Dowty JG, Hopper JL, Southey MC. Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases. Int J Cancer. 2009;124:x-i.
34. Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126-133.
35. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndroe among patients with colorectal cancer. J Clin Oncol. 2008;26:5783-5788.
36. Pérez-Carbonell L, Ruiz-Ponte C, Guarinos C, et al. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut. 2012;61:865-872.
37. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35-41.
38. Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS. Lynch syndrome screening implementation: business analysis by a healthcare system. Am J Manag Care. 2011;17:e288-e300.
39. Mvundura M, Grosse SD, Hampel H, Palomaki GE. The costeffectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010;12:93-104.